Navigation Links
Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
Date:12/13/2011

cent) of evaluable patients had nearly complete inhibition (>90 percent) of tFLT3 levels by the end of the first week of dosing.  Total FLT3 levels, as well as quizartinib-driven decreases in these levels correlated significantly with patients' peripheral blast counts and reductions in peripheral blast counts, respectively.  These findings suggest that the Ambit-developed assay can effectively track effects of drug administration on peripheral disease burden, and that further exploration is merited to determine the potential clinical utility in the future disease management of AML. 

Quizartinib (AC220), a Potent and Specific FLT3 Inhibitor, Enhances the Activity of Combined Cytarabine and Daunorubicin Chemotherapy in a FLT3-ITD Model of AML

Induction chemotherapy with a combination of cytarabine and an anthracycline (e.g. daunorubicin) is the first-line standard of care in the clinical management of AML patients.  To investigate the potential role of quizartinib in this setting, a series of three in vivo preclinical studies were performed using a solid tumor bearing mouse model with a leukemic cell line harboring the FLT3-ITD mutation (MV4-11).  The effect of quizartinib and standard chemotherapy alone and in combination with one another were assessed and compared.  Study 1 explored the effects of a low dose of quizartinib alone (1 mg/kg), cycles of cytarabine (Ara-C) alone (60 mg/kg), and in combination.  Study 2 explored the effects of a low dose of quizartinib alone (0.5 mg/kg), cycles of Ara-C + daunorubicin (DNR) (80 mg/kg and1 mg/kg, respectively) as a regimen alone, and in combination.  Study 3 explored the effects of a high dose of quizartinib alone (10 mg/kg), cycles of Ara-C + DNR (80 mg/kg and 1 mg/kg, respectively) as a regimen alone, and in combination.  In all studies, multiple quizartinib dosing schedules were evaluated, including both the episodic dosing of qu
'/>"/>

SOURCE Ambit Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. Ambit Biosciences Announces Transition in Company Leadership
3. Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia
4. Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
5. Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back
6. Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients
7. CV Therapeutics Board of Directors Rejects Astellas Tender Offer
8. CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas Tender Offer
9. CV Therapeutics Board of Directors Rejects Astellas Unsolicited Proposal
10. CV Therapeutics Statement on Unsolicited Proposal From Astellas
11. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 The Pistoia Alliance, ... lowering the barriers to innovation in life sciences ... of Carmen Nitsche as Executive Director Business Development ... its global reach. , Carmen joins the Pistoia ... Corporate Development. At Accelrys, she managed various life ...
(Date:9/16/2014)... -- This report analyzes the worldwide markets for Bioinformatics in ... Biocontent. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ... these markets. Market data and analytics are derived from primary ...
(Date:9/16/2014)... emerging field of molecular electronics could take our ... the construction of tiny circuits from molecular components. ... take on the roles currently played by comparatively-bulky ... researchers from five Japanese and Taiwanese universities has ... electronics: a molecule called picene. In a paper ...
(Date:9/16/2014)... BlueInGreen® , a water quality company offering ... gases into liquids, announced the addition of ... firm to its sales network. H2Flow will promote ... wastewater applications in the Canadian provinces of Ontario ... and serves Quebec and Ontario markets for water, ...
Breaking Biology Technology:Pistoia Alliance Expands Business Development with Appointment of Carmen Nitsche 2Global Bioinformatics Industry 2Global Bioinformatics Industry 3Global Bioinformatics Industry 4Global Bioinformatics Industry 5Global Bioinformatics Industry 6Global Bioinformatics Industry 7Global Bioinformatics Industry 8Global Bioinformatics Industry 9Global Bioinformatics Industry 10Global Bioinformatics Industry 11Global Bioinformatics Industry 12Global Bioinformatics Industry 13Global Bioinformatics Industry 14Global Bioinformatics Industry 15Global Bioinformatics Industry 16Global Bioinformatics Industry 17Global Bioinformatics Industry 18Global Bioinformatics Industry 19Global Bioinformatics Industry 20Global Bioinformatics Industry 21Global Bioinformatics Industry 22Global Bioinformatics Industry 23The future face of molecular electronics 2BlueInGreen® Expands into Canada – Signs Representative Agreement with H2Flow Equipment Inc. 2
... April 10 Senior experts from PAREXEL,International Corporation ... provider, will discuss best practices for,successful partnerships at ... held April 14-16, 2008 in Las Vegas, Nevada. ... PAREXEL experts will present in the following sessions, ...
... SANTA CLARA, Calif., April 10 Dedicating this year,s,Venture ... Burrill &,Company have announced a partnership in developing and ... the most promising and,innovative seed and early-stage life sciences ... Life Sciences Venture Forum will take place on,May 30, ...
... WA, April 10 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ... preclinical studies,of PX-478, pharmacodynamic studies of PX-12 and ... Annual Meeting of the American Association,for Cancer Research ... Oncothyreon is currently conducting a Phase 1 clinical ...
Cached Biology Technology:PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference 2PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference 3PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference 4Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum 2Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum 3Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting 2Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting 3
(Date:9/17/2014)... MRSA and MSSA could be curbed by coating ... scaly surface of shark skin, according to research ... Resistance and Infection Control . , The study ... of human disease bacteria through touching, sneezes or ... of ridges formulated to resemble shark skin. The ...
(Date:9/16/2014)... the "molecular brakes" that time the generation of important ... "hair cells" translate sound waves into electrical signals that ... sounds. If the arrangement of the cells is disordered, ... research will be published in The Journal of ... and Hey2 act as brakes to prevent hair cell ...
(Date:9/16/2014)... The meteorite impact that spelled doom for the dinosaurs ... flowering plants to a much greater extent than their ... researchers. The results are published in the journal ... a treasure trove of thousands of fossilized leaves of ... team was able to reconstruct the ecology of a ...
Breaking Biology News(10 mins):Sharks' skin has teeth in the fight against hospital superbugs 2Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Meteorite that doomed dinosaurs remade forests 2Meteorite that doomed dinosaurs remade forests 3Meteorite that doomed dinosaurs remade forests 4
... group of hormones that includes cortisol, are considered stress ... relationship to stress was first identified, it was shown ... cope with the physical demands of stress. Subsequently, high ... stress-related disorders, giving rise to the hypothesis that high ...
... is available in German . , ... cotton bollworm ( Helicoverpa armigera ) are dreaded pests all over ... different plant species are known as potential food for the voracious ... Asia, New Zealand, and Australia. Nearly 30% of all globally used ...
... September 12, 2012 The California Institute for Regenerative ... Huei-Sheng Vincent Chen, Ph.D., associate professor at Sanford-Burnham Medical ... new projects funded as part of CIRM,s Basic Biology ... increasing our understanding of stem cells and how to ...
Cached Biology News:Stress hormones: Good or bad for posttraumatic stress disorder risk? 2Insecticide resistance caused by recombination of 2 genes 2Insecticide resistance caused by recombination of 2 genes 3California's stem cell agency boosts heart disease research at Sanford-Burnham 2
Human Apolipoprotein B100 Affinity Purified Polyclonal Ab ENTREZ GeneID: 338...
Mouse Ameloblastin Biotinylated Affinity Purified PAb ENTREZ GeneID: 11698...
Human SOST Affinity Purified Polyclonal Ab...
Homo sapiens CDC23 (cell division cycle 23, yeast, homolog),...
Biology Products: